Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort

G. S. Alarcón, M. F. Ugarte-Gil, G. Pons-Estel, L. M. Vilá, J. D. Reveille, G. McGwin

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

28 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort'. En conjunto forman una huella única.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry